BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Veeda Clinical Research Limited

Offer Period :

-

Veeda Clinical Research Limited IPO Details

IPO Date - Minimum Investment ₹ / Lots
Listing Date Maximum Investment ₹ / Lots
Face Value ₹0 per share Total Issue Size ₹0 Crores
Price ₹0 to ₹0 per share Fresh Issue ₹0 Crores
Lot Size 1 Lots (0 Shares) Offer For Sale ₹ [-]
Listing At Retail Discount ₹ 0
Employee Discount ₹0 per Share Shareholding Pre Issue 65777495 Shares
Issue Type Shareholding Post Issue 0 Shares
IPO Date -
Listing Date
Face Value ₹0 per share
Price ₹0 to ₹0 per share
Lot Size 1 Lots (0 Shares)
Listing At
Total Issue Size ₹0 Crores
Employee Discount ₹0 per share
Issue Type
Minimum Investment ₹ / Lots
Maximum Investment ₹ / Lots
Fresh Issue ₹0 Crores
Offer For Sale ₹[-] Crores
Retail Discount ₹0 Crores
Shareholding Pre Issue 65777495 Shares
Shareholding Post Issue 0 Shares

About Veeda Clinical Research Limited IPO

Founding Head:

Managing Director: Mahesh Kantilal Bhalgat

Veeda Clinical Research Limited Timeline

Important dates for allocation and IPO listing.

-

IPO Opens

-

IPO Close

-

Allotment Date

-

Initiation of Refund

-

Credit of Shares to Demat Account

-

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 0 0
Public Group 0 0

Veeda Clinical Research Limited IPO Reservation

QIB Shares Offered 0(0%)
NII (HNI) Shares Offered 0(0%)
Retail Shares Offered 0(0%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

Veeda Clinical Research Limited IPO Lot Size

Application Lots Shares Amount
Retail (Min) [-] [-] ₹[-]
Retail (Max) [-] [-] ₹[-]
S HNI (Min) [-] [-] ₹[-]
S HNI (Max) [-] [-] ₹[-]
B HNI (MIN) [-] [-] ₹[-]

Veeda Clinical Research Limited IPO Anchor Investor Details

Bid Date
Shares Offered
Anchor Portion Size

Veeda Clinical Research Limited IPO Registrar

MUFG Intime India Pvt Ltd
Phone Number + 91 81081 14949
Email Id Veedalifesciences.ipo@linkintime.co.in
Our Website www.linkintime.co.in

Veeda Clinical Research Limited IPO Lead Manager

1. Axis Capital Ltd

2. CLSA India Pvt ltd

3. IIFL Capital Services Ltd

4. SBI Capital Markets Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Veeda Clinical Research Limited Financial Information

Period Ended March 31, 2024 March 31, 2023 March 31, 2022
Net Worth ₹892.04 ₹521.54 ₹473.76
Reserves and Surplus ₹879.44 ₹510.97 ₹463.18
Total Borrowing ₹0 ₹0 ₹0

Veeda Clinical Research Limited IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 0 0 0
Non Institutional Investors (NIIs) 0 0 0
NII(Bid amount of more than Ten Lakh Rupees) 0 0 0
NII(Bid amount of more than 2 Lakh < 10 Rupees) 0 0 0
Retail Individual Investors (RIIs) 0 0 0
Total 0 0 0

Strength of Veeda Clinical Research Limited

1. A platform for drug development needs of customers.

2. Successful integration of growth opportunities through acquisitions.

3. Strong scientific capabilities across business services.

4. Established quality credentials with a strong focus on quality control management.

5. Global and diverse management team with deep scientific expertise.

Risks Involved

1. The company derives a significant portion of its revenue from contracts with the company top clients. Its top five clients contributed more than 41.16% of the company revenue from contract with customers in the six months period ended September 30, 2024 with its top client that contributed approximately 28.37% of the company revenue from contract with customers in the six months period ended September 30, 2024. Loss of any of these clients could adversely affect its business, results of operations, cash flows and financial condition.

2. The potential loss or delay under any of its large contracts or of multiple key client contracts could adversely affect the company financial results specifically since the relationship of backlog to revenues varies over time and may not be fully realisable in the event of contract cancellation.

3. The company required to perform its services in accordance with contractual requirements, regulatory standards in applicable jurisdictions and ethical considerations. Any adverse action by any authority, including the Food and Drug Administration or the European Medicines Agency against it would negatively impact on the company ability to offer its services to the company clients and adversely impact its business and prospects.

4. If the company fails to deliver services in accordance with contractual requirements, the company could be subject to significant costs or liability and its reputation could be harmed.

5. The company has incurred losses for the six months period ended September 30, 2024 and Financial Year 2024 and may continue to do so in the future, which may adversely impact its business and the value of the Equity Shares.

6. The company financial performance is dependent on the company ability to secure business from clients in the pharmaceutical and biopharmaceutical industry. Consequently, any adverse changes in outsourcing trends in the pharmaceutical and biopharmaceutical industry and changes in aggregate spending and research and development budgets could adversely affect its operating results and growth rate.

7. The company studies and clinical trials could subject it to potential liability that may adversely affect its business, results of operations, cash flows and financial condition.

8. The company may not derives the anticipated benefits from its strategic investments and acquisitions, including the company acquisition of Heads and its may not be successful in pursuing future investments and acquisitions.

9. Failures to maintain confidential information of the company clients could adversely affect its business, results of operations, cash flows and financial condition and/or reputation.

10. The company is subject to risks arising from interest rate which could adversely affect its business, results of operations, cash flows and financial condition.

Why should you invest in

-

Veeda Clinical Research Limited Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023 2022
Total Assets 2027.95 734.77 677.54
Total Liabilities 2027.95 734.77 677.54
Total Expenses 404.73 358.06 261.64
Total Revenue 
407.99 420.21 293.11
Profit After Tax -0.22 40.12 50.46
EBITDA 71.21 114.05 100.63
Adjusted EBITDA 0 0 0

Veeda Clinical Research Limited IPO Contact Details

Veeda Clinical Research Limited IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
0 -
INE01HQ01026
₹0 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹0 ₹0
Open ₹0 ₹0
Low ₹0 ₹0
High ₹0 ₹0
Low ₹0 ₹0

Frequently Asked Questions

What is Veeda Clinical Research Limited IPO?

Answer Field

Veeda Clinical Research Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on .

When Veeda Clinical Research Limited IPO will open?

Answer Field

The Veeda Clinical Research Limited IPO opens on [-] and closes on [-].

What is the lot size of Veeda Clinical Research Limited?

Answer Field

Veeda Clinical Research Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Veeda Clinical Research Limited IPO?

Answer Field

You can apply in Veeda Clinical Research Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Veeda Clinical Research Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Veeda Clinical Research Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Veeda Clinical Research Limited IPO listing date?

Answer Field

The Veeda Clinical Research Limited listing date is [-].

Who is the registrar of Veeda Clinical Research Limited IPO?

Answer Field

The registrar of Veeda Clinical Research Limited IPO is MUFG Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Axis Capital Ltd,CLSA India Pvt ltd,IIFL Capital Services Ltd,SBI Capital Markets Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Veeda Clinical Research Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Veeda Clinical Research Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Veeda Clinical Research Limited IPO?

Answer Field

To apply for Veeda Clinical Research Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Veeda Clinical Research Limited?

Answer Field

The price of each Veeda Clinical Research Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Veeda Clinical Research Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • GLEN INDUSTRIES LIMITEDSME IPO

  • Bidding Dates

    8th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹92.0 - 97.0

  • IPO Size

    ₹63,02,00,000

  • Apply Now
  • CFF FLUID CONTROL LIMITEDSME IPO

  • Bidding Dates

    9th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹585.0 - 585.0

  • IPO Size

    ₹87,75,00,000

  • Apply Now
  • SPUNWEB NONWOVEN LIMITEDSME IPO Early Access

  • Bidding Dates

    14th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹90.0 - 96.0

  • IPO Size

    ₹60,98,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • CRIZAC LIMITEDMainboard IPO

  • Bidding Dates

    2nd Jul 2025 - 7th Jul 2025

  • Price Range

    ₹233.0 - 245.0

  • IPO Size

    ₹8,60,00,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • CRIZAC LIMITEDMainboard IPO

  • Issue Price

    245.00

  • Listing Day Close

    307.45

  • Listing Day (Gain/Loss)

    25.31

  • VANDAN FOODS LIMITEDSME IPO

  • Issue Price

    115.00

  • Listing Day Close

    118.75

  • Listing Day (Gain/Loss)

    3.48

  • NEETU YOSHI LIMITEDSME IPO

  • Issue Price

    75.00

  • Listing Day Close

    110.25

  • Listing Day (Gain/Loss)

    46.67

  • PRO FX TECH LIMITEDSME IPO

  • Issue Price

    87.00

  • Listing Day Close

    99.75

  • Listing Day (Gain/Loss)

    14.94

  • SUPERTECH EV LIMITEDSME IPO

  • Issue Price

    92.00

  • Listing Day Close

    69.92

  • Listing Day (Gain/Loss)

    -23.91

  • RAMA TELECOM LIMITEDSME IPO

  • Issue Price

    68.00

  • Listing Day Close

    68.40

  • Listing Day (Gain/Loss)

    0.00

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.2 App Rating

icon-with-text

4 Languages

icon-with-text

₹5600+ Cr MTF Book

icon-with-text